<th id="5q2pv"></th>
    1. <dd id="5q2pv"><track id="5q2pv"></track></dd>

      <th id="5q2pv"></th>
      <th id="5q2pv"></th>
      <button id="5q2pv"></button>
      <em id="5q2pv"></em>
      1. <dd id="5q2pv"><track id="5q2pv"></track></dd>

        <th id="5q2pv"></th>

        <tbody id="5q2pv"></tbody>
        <rp id="5q2pv"></rp>

        首頁 > ENGLISH

        Company profile

                Shanghai Institute of Biological Products Co., Ltd. (SIBP CNBG) is a subsidiary of China National Biotech Group Corporation (CNBG), China National Pharmaceutical Group Corporation. SIBP CNBG was established in September 1949, it is the main research institution of national medical microbiology, immunology, cell engineering, genetic engineering and blood products, and it is a high-tech enterprise integrating the production, study, research and marketing of biological products recognized by the state. SIBP CNBG is one of the first batch of master degree awarding units in biochemistry, molecular biology and pathogenic biology, its predecessor is Shanghai Biological Products Factory, which is directly under the leadership of the Ministry of Health.
                At present, the main products of SIBP CNBG are biological products for prevention. Measles, Mumps and Rubella combined vaccine, live, Influenza Vaccine (Split Virion), Inactivated and Varicella Vaccine, Live have won the titles of "key new products" of the state and Shanghai respectively, and "famous products" in Shanghai pharmaceutical industry. "Shangsheng" brand has won the title of "Shanghai famous trademark" for many times.
                Since the seventh five-year plan and the eighth five-year plan, SIBP CNBG has undertaken and completed dozens of national, provincial and ministerial scientific research tasks, such as "863", "973", "scientific and technological support", "major new drug creation", "major special project of infectious diseases", etc, and made more than 100 scientific research achievements, of which more than 30  won Awards of  Science and Technology Progress set by State Science and Technology Commission, the Ministry of Health or the Shanghai Municipality, which include the first and second prizes of national science and technology, the second and third prizes of Shanghai science and technology, and the top ten independent innovation of Shanghai. Over the past few decades, SIBP CNBG has maintained friendly exchanges with more than 20 countries and regions such as the United States, the Netherlands, Japan, South Korea, Egypt, Brazil and Cuba, and has carried out technical exchanges and trade cooperation.

         

        天天做天天大爽天天爱首页-天天做天天爱天天爽天天综合网,天天做天天大爽天天爱